List view / Grid view
31 October 2016 | By Niamh Louise Marriott, Digital Content Producer
The Swiss Agency for Therapeutic Products, Swissmedic, has approved Alprolix (eftrenonacog alfa) for the treatment of haemophilia B...
31 October 2016 | By Niamh Louise Marriott, Digital Content Producer
The US Food and Drug Administration (FDA) has approved Roche’s PD-L1 assay as a diagnostic to identify PD-L1 expression levels in patients considering treatment with Tecentriq (atezolizumab) for previously treated metastatic non-small cell lung cancer (NSCLC). The PD-L1 (SP142) assay is also indicated to identify patients with urothelial cancer (UC)…
28 October 2016 | By ESP
Enterprise System Partners (ESP) has formally signed a partnership agreement with GS1 Ireland to work collaboratively in the development and delivery of the highest anti-counterfeiting solutions based on GS1 standards to the biopharmaceutical manufacturing industry...
28 October 2016 | By ESP
In collaboration with our partners GS1 Ireland, ESP carried out an extensive industry survey to establish the status of the industry in relation to the impending serialisation deadlines, which are facing us in the coming months and years...
28 October 2016 | By Niamh Louise Marriott, Digital Content Producer
Brussels Airport presented a European first at the TIACA Air Cargo Forum in Paris: the active version of the "Airside Pharma Transporter"...
28 October 2016 | By Niamh Louise Marriott, Digital Content Producer
Results of a Phase 2b trial of relamorelin, Motus' ghrelin agonist, for the treatment of gastroparesis in diabetics has led to Allergan acquiring Motus...
28 October 2016 | By Dolomite Bio
Dolomite Bio’s Single Cell RNA-Seq System is helping researchers at the University of Helsinki to investigate autoimmune diseases. Focusing on gastrointestinal conditions – such as coeliac disease and inflammatory bowel disease – the Molecular Genetics of Immunological Diseases group is using the system to study T-cell activation and response at…
28 October 2016 | By Niamh Louise Marriott, Digital Content Producer
The proposed phase III study design reviewed by the FDA guidance focuses on overall survival as the primary endpoint, including Leukaemia Free Survival...
28 October 2016 | By Niamh Louise Marriott, Digital Content Producer
The results of ObsEva’s trial of OBE001 (nolasiban) showed improvement in clinical pregnancy and live birth rates in women undergoing embryo transfer...
27 October 2016 | By Niamh Louise Marriott, Digital Content Producer
Clobazam oral suspension is used principally as an adjunctive therapy for epilepsy with the formulation particularly suitable for children and young adults...
27 October 2016 | By Niamh Louise Marriott, Digital Content Producer
The Japanese Phase III clinical trial is a double-blinded, randomised, parallel-group comparison of efficacy and safety of FP-1201-lyo against placebo...
27 October 2016 | By Niamh Louise Marriott, Digital Content Producer
Phase 3 study was designed to demonstrate the safety and efficacy of CAM2038 as compared to the sublingual buprenorphine in treating opioid use disorder...
26 October 2016 | By Cobalt Light Systems
The United States Food and Drug Administration (FDA) has purchased Cobalt’s TRS100 transmission Raman instrument for use by the Division of Pharmaceutical Analysis (DPA)...
26 October 2016 | By Dolomite
This year's MicroTAS Video Competition has been won by Enrica Rollo from EPFL (École polytechnique fédérale de Lausanne) in Switzerland, for her entertaining comparison between cleanrooms and kitchens...
25 October 2016 | By ROMIL
ROMIL is proud to announce the launch of its new website; an easy-to-use, interactive resource for laboratory professionals requiring high purity solvents, acids, reagents and reference materials. This user-friendly, comprehensive reference site has been redesigned from the ground up and optimised for PCs, tablets and smartphones, allowing straightforward browsing of…
